US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Therapeutics

29.00

-0.5800-1.96%

Post-market: 29.000.00000.00%19:54 EDT

Volume:156.51K

Turnover:4.55M

Market Cap:816.24M

PE:-16.39

High:29.52

Open:28.80

Low:28.57

Close:29.58

Loading ...

Overview Company News Filings

EXACT Therapeutics to Hold Separate Board Candidate Votes at AGM

IRLAB Therapeutics to Present at Aktiedagarna Event in Stockholm

Chimeric Therapeutics’ CHM CDH17 Receives FDA Fast Track Designation

William Blair Reaffirms Their Buy Rating on LENZ Therapeutics (LENZ)

Promising Growth and Diversification Drive Buy Rating for Crispr Therapeutics AG

Quince Therapeutics Says Enrollment for Phase 3 Clinical Trial in Ataxia-Telangiectasia Exceeds 75%

MT Newswires Live

Denali Therapeutics Enters Registration Rights Agreement

Silexion Therapeutics Requests Hearing on Nasdaq Delisting

Windtree Therapeutics announces plan for cryptocurrency treasury policy

Quince Therapeutics tops 75% enrollment in pivotal Phase 3 NEAT clinical trial

Enliven Therapeutics: Buy Rating Backed by Promising ELVN-001 Developments in CML Treatment

Indaptus Therapeutics: Promising Clinical Developments and Strategic Advances Justify Buy Rating

Solvonis Therapeutics Announces 2025 AGM Details Amidst Clinical Progress

Candel Therapeutics to hold a conference call

Kymera Therapeutics Is Maintained at Overweight by JP Morgan

Cognition Therapeutics Launches Expanded Access Program for Zervimesine

Vera Therapeutics Secures $500M Loan Agreement

JW Therapeutics Approves License Agreement at EGM

Press Release: Vera Therapeutics Announces Refinancing of Existing Oxford Debt Facility, Providing up to $500 Million of Term Loans

Solvonis Therapeutics Appoints Renowned Neuroscientist as Chief Scientific Officer

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/LENZ/news?page=8"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LENZ","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LENZ\",,,,,undefined,":{"symbol":"LENZ","market":"US","secType":"STK","nameCN":"Therapeutics","latestPrice":29,"timestamp":1749844800000,"preClose":29.58,"halted":0,"volume":156505,"hourTrading":{"tag":"盘后","latestPrice":29,"preClose":29,"latestTime":"19:54 EDT","volume":608,"amount":17570.81,"timestamp":1749858862399},"delay":0,"floatShares":11653723,"shares":28146154,"eps":-1.769251,"marketStatus":"Not Yet Opened","change":-0.58,"latestTime":"06-13 16:00:00 EDT","open":28.8,"high":29.52,"low":28.565,"amount":4554492.6963,"amplitude":0.032285,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.769251,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1750060800000},"marketStatusCode":0,"adr":0,"listingDate":1624593600000,"exchange":"NASDAQ","adjPreClose":29.58,"preHourTrading":{"tag":"盘前","latestPrice":28.84,"preClose":29.58,"latestTime":"09:29 EDT","volume":77,"amount":2235.719948,"timestamp":1749821370092},"postHourTrading":{"tag":"盘后","latestPrice":29,"preClose":29,"latestTime":"19:54 EDT","volume":608,"amount":17570.81,"timestamp":1749858862399},"volumeRatio":0.2990981094374136,"impliedVol":0.5592,"impliedVolPercentile":0.5435},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LENZ\",,,,,undefined,":{"symbol":"LENZ","floatShares":11653723,"roa":"-17.75%","roe":"-24.47%","lyrEps":-2.338654,"volumeRatio":0.2990981094374136,"shares":28146154,"dividePrice":0,"high":29.52,"amplitude":0.032285,"preClose":29.58,"low":28.565,"week52Low":16.28,"pbRate":"4.25","week52High":38.93,"institutionHeld":0,"latestPrice":29,"eps":-1.769251,"divideRate":0,"volume":156505,"delay":0,"ttmEps":-1.769251,"open":28.8,"prevYearClose":28.87,"prevWeekClose":31.96,"prevMonthClose":29.2,"prevQuarterClose":25.71,"fiveDayClose":31.96,"twentyDayClose":27.34,"sixtyDayClose":25.52},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LENZ\",pageSize:20,pageCount:8,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2540032678","title":"EXACT Therapeutics to Hold Separate Board Candidate Votes at AGM","url":"https://stock-news.laohu8.com/highlight/detail?id=2540032678","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540032678?lang=en_us&edition=fundamental","pubTime":"2025-06-04 15:32","pubTimestamp":1749022375,"startTime":"0","endTime":"0","summary":"EXACT Therapeutics AS ( ($DE:56F) ) just unveiled an update. EXACT Therapeutics AS announced that during their upcoming Annual General Meeting, sep...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/exact-therapeutics-to-hold-separate-board-candidate-votes-at-agm?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/exact-therapeutics-to-hold-separate-board-candidate-votes-at-agm?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BK4139","BK4539","LENZ","BK4229","AGM","BK4195"],"gpt_icon":0},{"id":"2540363370","title":"IRLAB Therapeutics to Present at Aktiedagarna Event in Stockholm","url":"https://stock-news.laohu8.com/highlight/detail?id=2540363370","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540363370?lang=en_us&edition=fundamental","pubTime":"2025-06-04 13:33","pubTimestamp":1749015185,"startTime":"0","endTime":"0","summary":"IRLAB Therapeutics AB Class A ( ($SE:IRLAB.A) ) has issued an announcement. IRLAB Therapeutics AB announced its participation in the Aktiedagarna e...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/irlab-therapeutics-to-present-at-aktiedagarna-event-in-stockholm?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/irlab-therapeutics-to-present-at-aktiedagarna-event-in-stockholm?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","BK4007","BK4139","LENZ"],"gpt_icon":0},{"id":"2540893270","title":"Chimeric Therapeutics’ CHM CDH17 Receives FDA Fast Track Designation","url":"https://stock-news.laohu8.com/highlight/detail?id=2540893270","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540893270?lang=en_us&edition=fundamental","pubTime":"2025-06-04 09:17","pubTimestamp":1748999860,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Chimeric Therapeutics Ltd. ( ($AU:CHM) ). Chimeric Therapeutics announced that its CHM CDH17 therapy has receiv...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/chimeric-therapeutics-chm-cdh17-receives-fda-fast-track-designation?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/chimeric-therapeutics-chm-cdh17-receives-fda-fast-track-designation?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BK4585","IE00BFXG0V08.USD","BK4139","BK4539","IE00B5TLWC47.USD","BK4567","BK4588","BK4104","LENZ","FAST","IE00BYQQ9H92.USD"],"gpt_icon":0},{"id":"2540700041","title":"William Blair Reaffirms Their Buy Rating on LENZ Therapeutics (LENZ)","url":"https://stock-news.laohu8.com/highlight/detail?id=2540700041","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540700041?lang=en_us&edition=fundamental","pubTime":"2025-06-04 06:35","pubTimestamp":1748990114,"startTime":"0","endTime":"0","summary":"William Blair analyst Lachlan Hanbury Brown maintained a Buy rating on LENZ Therapeutics (LENZ – Research Report) today. The company’s shares close...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/william-blair-reaffirms-their-buy-rating-on-lenz-therapeutics-lenz-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/william-blair-reaffirms-their-buy-rating-on-lenz-therapeutics-lenz-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ"],"gpt_icon":0},{"id":"2540770063","title":"Promising Growth and Diversification Drive Buy Rating for Crispr Therapeutics AG","url":"https://stock-news.laohu8.com/highlight/detail?id=2540770063","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540770063?lang=en_us&edition=fundamental","pubTime":"2025-06-04 05:55","pubTimestamp":1748987714,"startTime":"0","endTime":"0","summary":"William Blair analyst Sami Corwin has reiterated their bullish stance on CRSP stock, giving a Buy rating on May 21. Sami Corwin has given his Buy r...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/promising-growth-and-diversification-drive-buy-rating-for-crispr-therapeutics-ag-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/promising-growth-and-diversification-drive-buy-rating-for-crispr-therapeutics-ag-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AG","LENZ","CRSP"],"gpt_icon":0},{"id":"2540086707","title":"Quince Therapeutics Says Enrollment for Phase 3 Clinical Trial in Ataxia-Telangiectasia Exceeds 75%","url":"https://stock-news.laohu8.com/highlight/detail?id=2540086707","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540086707?lang=en_us&edition=fundamental","pubTime":"2025-06-04 05:36","pubTimestamp":1748986575,"startTime":"0","endTime":"0","summary":"Quince Therapeutics  said late Tuesday that the enrollment in its phase 3 clinical trial of the neurological effects of eDSP system on Ataxia-Telangiectasia patients has exceeded 75%.EDSP is comprised of dexamethasone sodium phosphate encapsulated in a patient's own red blood cells.A total of 76 participants have been enrolled, including 65 participants in the six- to nine-year-old primary analysis population and 11 participants aged 10 years or above, the company said.The company said it plans to submit a new drug application to the US Food and Drug Administration in H2 2026, subject to a positive outcome of the trial.The company said it received the FDA's fast track designation for eDSP system for the treatment of patients with Ataxia-Telangiectasia, a rare neurodegenerative disease.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4539","QNCX","LENZ","BK4007","BK4139"],"gpt_icon":0},{"id":"2540702480","title":"Denali Therapeutics Enters Registration Rights Agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2540702480","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540702480?lang=en_us&edition=fundamental","pubTime":"2025-06-04 04:39","pubTimestamp":1748983144,"startTime":"0","endTime":"0","summary":"Denali Therapeutics ( ($DNLI) ) has provided an update. On June 3, 2025, Denali Therapeutics entered into a registration rights agreement with Bake...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/denali-therapeutics-enters-registration-rights-agreement?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/denali-therapeutics-enters-registration-rights-agreement?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","BK4539","BK4007","BK4139"],"gpt_icon":0},{"id":"2540702498","title":"Silexion Therapeutics Requests Hearing on Nasdaq Delisting","url":"https://stock-news.laohu8.com/highlight/detail?id=2540702498","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540702498?lang=en_us&edition=fundamental","pubTime":"2025-06-04 04:36","pubTimestamp":1748982987,"startTime":"0","endTime":"0","summary":"Silexion Therapeutics ( ($SLXN) ) has shared an update. On May 28, 2025, Silexion Therapeutics Corp requested a hearing regarding a delisting notic...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/silexion-therapeutics-requests-hearing-on-nasdaq-delisting?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/silexion-therapeutics-requests-hearing-on-nasdaq-delisting?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NDAQ","BK4539","USAW.SI","LU2210150020.SGD","USJW.SI","TSYW.SI","IE00B3QW5Z07.USD","QLD","SQQQ","BK4007","BK4585","NQmain","BK4588","LU2095319765.USD","PSQ","BK4112","LU2210149790.SGD","NVIW.SI","IE00BKPKM429.USD","IE00B64PRP62.GBP",".IXIC","MNQmain","TQQQ","IE00BGHQF748.EUR","BK4139","QID","LENZ"],"gpt_icon":0},{"id":"2540490702","title":"Windtree Therapeutics announces plan for cryptocurrency treasury policy","url":"https://stock-news.laohu8.com/highlight/detail?id=2540490702","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540490702?lang=en_us&edition=fundamental","pubTime":"2025-06-04 04:35","pubTimestamp":1748982918,"startTime":"0","endTime":"0","summary":"Windtree Therapeutics (WINT) announced that its board has agreed that the company will create a cryptocurrency policy that will allow the company t...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/windtree-therapeutics-announces-plan-for-cryptocurrency-treasury-policy-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/windtree-therapeutics-announces-plan-for-cryptocurrency-treasury-policy-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["US7Y.BOND","US12M.BOND","US2Y.BOND","LENZ","US10Y.BOND","US5Y.BOND","US6M.BOND","BK4139","BK4007","US3Y.BOND","US30Y.BOND","WINT","BK4539"],"gpt_icon":0},{"id":"2540040257","title":"Quince Therapeutics tops 75% enrollment in pivotal Phase 3 NEAT clinical trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2540040257","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540040257?lang=en_us&edition=fundamental","pubTime":"2025-06-04 04:15","pubTimestamp":1748981751,"startTime":"0","endTime":"0","summary":"Quince Therapeutics (QNCX) “announced that its pivotal Phase 3 NEAT clinical trial in the rare neurodegenerative disease Ataxia-Telangiectasia (A-T...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/quince-therapeutics-tops-75-enrollment-in-pivotal-phase-3-neat-clinical-trial-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/quince-therapeutics-tops-75-enrollment-in-pivotal-phase-3-neat-clinical-trial-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BK4539","BK4139","LENZ","QNCX"],"gpt_icon":0},{"id":"2540970983","title":"Enliven Therapeutics: Buy Rating Backed by Promising ELVN-001 Developments in CML Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2540970983","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540970983?lang=en_us&edition=fundamental","pubTime":"2025-06-04 01:35","pubTimestamp":1748972112,"startTime":"0","endTime":"0","summary":"JonesTrading analyst Soumit Roy has maintained their bullish stance on ELVN stock, giving a Buy rating on May 29. Soumit Roy has given his Buy rati...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/enliven-therapeutics-buy-rating-backed-by-promising-elvn-001-developments-in-cml-treatment-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/enliven-therapeutics-buy-rating-backed-by-promising-elvn-001-developments-in-cml-treatment-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","ELVN"],"gpt_icon":0},{"id":"2540703987","title":"Indaptus Therapeutics: Promising Clinical Developments and Strategic Advances Justify Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2540703987","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540703987?lang=en_us&edition=fundamental","pubTime":"2025-06-03 23:35","pubTimestamp":1748964915,"startTime":"0","endTime":"0","summary":"In a report released yesterday, Jason McCarthy from Maxim Group maintained a Buy rating on Indaptus Therapeutics (INDP – Research Report), with a p...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/indaptus-therapeutics-promising-clinical-developments-and-strategic-advances-justify-buy-rating-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/indaptus-therapeutics-promising-clinical-developments-and-strategic-advances-justify-buy-rating-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ"],"gpt_icon":0},{"id":"2540370396","title":"Solvonis Therapeutics Announces 2025 AGM Details Amidst Clinical Progress","url":"https://stock-news.laohu8.com/highlight/detail?id=2540370396","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540370396?lang=en_us&edition=fundamental","pubTime":"2025-06-03 23:32","pubTimestamp":1748964741,"startTime":"0","endTime":"0","summary":"Graft Polymer (UK) PLC ( ($GB:SVNS) ) has shared an announcement. Solvonis Therapeutics plc has announced the posting of its 2025 Annual General Me...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/solvonis-therapeutics-announces-2025-agm-details-amidst-clinical-progress?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/solvonis-therapeutics-announces-2025-agm-details-amidst-clinical-progress?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","AGM","BK4528","UK","BK4139","LU2065732104.USD","BK4195","BK4205","LENZ","PRGS","BK4007","BK4097","BK4233","BK4229"],"gpt_icon":0},{"id":"2540708300","title":"Candel Therapeutics to hold a conference call","url":"https://stock-news.laohu8.com/highlight/detail?id=2540708300","media":"TIPRANKS","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540708300?lang=en_us&edition=fundamental","pubTime":"2025-06-03 22:35","pubTimestamp":1748961311,"startTime":"0","endTime":"0","summary":"Management discusses expert clinical perspectives on CAN-2409 Phase 3 prostate cancer data on a conference call to be held on June 3 at 1 pm. Webca...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/candel-therapeutics-to-hold-a-conference-call-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/candel-therapeutics-to-hold-a-conference-call-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","BK4595","BK4139","BK4170","LENZ","CADL","BK4600","BK4007","BK4526"],"gpt_icon":0},{"id":"2540771333","title":"Kymera Therapeutics Is Maintained at Overweight by JP Morgan","url":"https://stock-news.laohu8.com/highlight/detail?id=2540771333","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540771333?lang=en_us&edition=fundamental","pubTime":"2025-06-03 20:21","pubTimestamp":1748953260,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/KYMR/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  June 03, 2025 08:21 ET (12:21 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KYMR","LENZ"],"gpt_icon":0},{"id":"2540572779","title":"Cognition Therapeutics Launches Expanded Access Program for Zervimesine","url":"https://stock-news.laohu8.com/highlight/detail?id=2540572779","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540572779?lang=en_us&edition=fundamental","pubTime":"2025-06-03 19:57","pubTimestamp":1748951873,"startTime":"0","endTime":"0","summary":"Cognition Therapeutics ( ($CGTX) ) just unveiled an announcement. On June 3, 2025, Cognition Therapeutics announced the launch of an expanded acces...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/cognition-therapeutics-launches-expanded-access-program-for-zervimesine?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/cognition-therapeutics-launches-expanded-access-program-for-zervimesine?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","LENZ","BK4539","BK4007","CGTX"],"gpt_icon":0},{"id":"2540775634","title":"Vera Therapeutics Secures $500M Loan Agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2540775634","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540775634?lang=en_us&edition=fundamental","pubTime":"2025-06-03 18:57","pubTimestamp":1748948278,"startTime":"0","endTime":"0","summary":"Vera Therapeutics ( ($VERA) ) has shared an announcement. On June 2, 2025, Vera Therapeutics entered into a Loan and Security Agreement with Oxford...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vera-therapeutics-secures-500m-loan-agreement?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vera-therapeutics-secures-500m-loan-agreement?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","VERA","BK4588","BK4585","LENZ","BK4007","BK4139"],"gpt_icon":0},{"id":"2540977318","title":"JW Therapeutics Approves License Agreement at EGM","url":"https://stock-news.laohu8.com/highlight/detail?id=2540977318","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540977318?lang=en_us&edition=fundamental","pubTime":"2025-06-03 18:38","pubTimestamp":1748947096,"startTime":"0","endTime":"0","summary":"The latest update is out from JW (Cayman) Therapeutics Co. Ltd. ( ($HK:2126) ). JW (Cayman) Therapeutics Co. Ltd held an Extraordinary General Meet...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/jw-therapeutics-approves-license-agreement-at-egm?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/jw-therapeutics-approves-license-agreement-at-egm?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4007","BK4539","LENZ"],"gpt_icon":0},{"id":"2540780497","title":"Press Release: Vera Therapeutics Announces Refinancing of Existing Oxford Debt Facility, Providing up to $500 Million of Term Loans","url":"https://stock-news.laohu8.com/highlight/detail?id=2540780497","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540780497?lang=en_us&edition=fundamental","pubTime":"2025-06-03 18:30","pubTimestamp":1748946600,"startTime":"0","endTime":"0","summary":"BRISBANE, Calif., June 03, 2025  -- Vera Therapeutics, Inc. , a late clinical-stage biotechnology company focused on developing and commercializing transformative treatments for patients with serious immunological diseases, today announced that it has entered into a new credit facility providing for up to $500 million of term loans with its current partner Oxford Finance LLC . The new credit facility will replace Vera's existing $50 million credit facility. The initial funding of the new credit facility will be in a principal amount of $75 million and is expected to occur on June 4, 2025.-- Lowered Interest Rate: Reduced borrowing cost by 320 basis points based. on current interest rates. The facility will mature five years from the. 2026, not subject to additional performance milestones. Vera has the. million at the mutual discretion of Vera and Oxford.this refinancing, Vera will no longer be required to make principal. in a cost-effective refinancing that significantly lowers Vera's ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4202","OXM","BK4213","BKV","BK4007","BK4539","VERA","LENZ","BK4139"],"gpt_icon":0},{"id":"2540742565","title":"Solvonis Therapeutics Appoints Renowned Neuroscientist as Chief Scientific Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2540742565","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540742565?lang=en_us&edition=fundamental","pubTime":"2025-06-03 14:16","pubTimestamp":1748931378,"startTime":"0","endTime":"0","summary":"Graft Polymer (UK) PLC ( ($GB:SVNS) ) has issued an announcement. Solvonis Therapeutics plc has appointed Professor David Nutt as Chief Scientific ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/solvonis-therapeutics-appoints-renowned-neuroscientist-as-chief-scientific-officer?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/solvonis-therapeutics-appoints-renowned-neuroscientist-as-chief-scientific-officer?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4205","BK4007","BK4539","BK4139","BK4233","UK","BK4528","LENZ"],"gpt_icon":0}],"pageSize":20,"totalPage":11,"pageCount":8,"totalSize":203,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LENZ\",params:#limit:5,,,undefined,":[{"market":"US","date":"2024-05-08","symbol":"LENZ","fiscalQuarterEnding":"2024/03","expectedEps":-0.84,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1715140800000,"reportTimeType":"pre","actualEps":-3.53},{"market":"US","date":"2024-03-22","symbol":"LENZ","defaultRemindTime":1711114200000,"type":"split","dateTimestamp":1711080000000,"forFactor":7,"toFactor":1,"ratio":7},{"date":"2024-03-22","symbol":"LENZ","amount":1.03,"announcedDate":null,"type":"dividend","market":"US","newRecordDate":"2024-03-18","name":"Therapeutics","recordDate":"2024-03-21","payableDate":"2024-03-18","currency":"USD","dateTimestamp":1711080000000,"payDate":"2024-03-21"},{"market":"US","date":"2021-08-12","symbol":"LENZ","fiscalQuarterEnding":"2021/06","expectedEps":-1.11,"name":null,"time":"","type":"earning","dateTimestamp":1628740800000,"reportTimeType":"","actualEps":-3.45}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LENZ\",market:\"US\",,,undefined,":[{"executeDate":"2024-03-22","recordDate":"2024-03-18","paymentDate":"2024-03-21","value":1.03,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LENZ\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5,"buy":0.5,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.5,"analysts":8,"updateTime":1742270400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/LENZ\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"LENZ","date":"2025-06-13","current":-17.439532,"percent":0.017422,"low":-18.842712,"twenty":-14.747436,"median":-10.384797,"eighty":-7.264924,"high":-5.069183,"avg":-10.841843,"sd":3.694257,"marketCap":832563235},"quantilePoints":[{"date":"2024-03-28","current":-7.959158,"twenty":-7.219077,"median":-6.108955,"eighty":-6.016992,"marketCap":556886354},{"date":"2024-04-05","current":-7.492045,"twenty":-7.873034,"median":-7.667213,"eighty":-6.662191,"marketCap":524203432},{"date":"2024-04-12","current":-7.929963,"twenty":-7.855517,"median":-7.667213,"eighty":-7.432197,"marketCap":554843672},{"date":"2024-04-19","current":-6.382653,"twenty":-7.855517,"median":-7.488396,"eighty":-6.783348,"marketCap":446581492},{"date":"2024-04-26","current":-5.638193,"twenty":-7.716113,"median":-7.451903,"eighty":-5.889996,"marketCap":394493084},{"date":"2024-05-03","current":-5.988527,"twenty":-7.671592,"median":-6.864363,"eighty":-5.803142,"marketCap":419005276},{"date":"2024-05-10","current":-5.317808,"twenty":-7.667213,"median":-6.108955,"eighty":-5.803142,"marketCap":393230653},{"date":"2024-05-17","current":-5.708011,"twenty":-7.597146,"median":-6.0013,"eighty":-5.749862,"marketCap":422084590},{"date":"2024-05-24","current":-5.428308,"twenty":-7.489126,"median":-6.006774,"eighty":-5.719496,"marketCap":401401679},{"date":"2024-05-31","current":-5.355793,"twenty":-7.479638,"median":-5.988527,"eighty":-5.522773,"marketCap":396039443},{"date":"2024-06-07","current":-5.193496,"twenty":-7.457742,"median":-5.904593,"eighty":-5.428999,"marketCap":384038248},{"date":"2024-06-14","current":-6.433167,"twenty":-7.451903,"median":-5.930138,"eighty":-5.428308,"marketCap":475706952},{"date":"2024-06-21","current":-6.236339,"twenty":-7.425628,"median":-5.992177,"eighty":-5.43107,"marketCap":461152311},{"date":"2024-06-28","current":-6.150011,"twenty":-7.389135,"median":-6.0013,"eighty":-5.439358,"marketCap":454768696},{"date":"2024-07-05","current":-6.098214,"twenty":-7.269437,"median":-6.014073,"eighty":-5.469746,"marketCap":450938528},{"date":"2024-07-12","current":-6.771573,"twenty":-6.771573,"median":-6.098214,"eighty":-5.493918,"marketCap":500730721},{"date":"2024-07-15","current":-7.261916,"twenty":-7.163847,"median":-6.103393,"eighty":-5.509112,"marketCap":536989651},{"date":"2024-08-02","current":-8.498134,"twenty":-7.266429,"median":-6.108573,"eighty":-5.524305,"marketCap":628403011},{"date":"2024-08-09","current":-8.328931,"twenty":-7.474529,"median":-6.146558,"eighty":-5.597209,"marketCap":615891126},{"date":"2024-08-16","current":-8.944708,"twenty":-7.671592,"median":-6.236339,"eighty":-5.641258,"marketCap":621424629},{"date":"2024-08-23","current":-8.79431,"twenty":-7.94748,"median":-6.352018,"eighty":-5.670717,"marketCap":610975896},{"date":"2024-08-30","current":-8.746816,"twenty":-8.006409,"median":-6.382653,"eighty":-5.719496,"marketCap":607676296},{"date":"2024-09-06","current":-9.451311,"twenty":-8.199004,"median":-6.419354,"eighty":-5.743293,"marketCap":656620360},{"date":"2024-09-13","current":-8.17293,"twenty":-8.352945,"median":-6.434893,"eighty":-5.773217,"marketCap":567806132},{"date":"2024-09-20","current":-8.7389,"twenty":-8.507104,"median":-6.459289,"eighty":-5.788545,"marketCap":607126363},{"date":"2024-09-27","current":-8.806184,"twenty":-8.638371,"median":-6.616182,"eighty":-5.792924,"marketCap":611800796},{"date":"2024-10-04","current":-8.897214,"twenty":-8.745233,"median":-7.269437,"eighty":-5.800953,"marketCap":618125029},{"date":"2024-10-11","current":-9.340491,"twenty":-8.850511,"median":-7.455552,"eighty":-5.81701,"marketCap":648921294},{"date":"2024-10-18","current":-10.417023,"twenty":-8.905129,"median":-7.492045,"eighty":-5.857882,"marketCap":723712222},{"date":"2024-10-25","current":-9.902504,"twenty":-9.0017,"median":-7.670862,"eighty":-5.904593,"marketCap":687966558},{"date":"2024-10-31","current":-10.939457,"twenty":-9.257377,"median":-7.718702,"eighty":-5.904593,"marketCap":760007820},{"date":"2024-11-08","current":-14.709443,"twenty":-9.419648,"median":-7.959158,"eighty":-5.955683,"marketCap":894466512},{"date":"2024-11-15","current":-15.344855,"twenty":-9.514636,"median":-8.00261,"eighty":-5.970448,"marketCap":933105265},{"date":"2024-11-22","current":-15.521232,"twenty":-9.76398,"median":-8.132103,"eighty":-5.988527,"marketCap":943830613},{"date":"2024-11-29","current":-16.100113,"twenty":-9.924668,"median":-8.17293,"eighty":-5.994366,"marketCap":979031755},{"date":"2024-12-06","current":-16.33076,"twenty":-10.388526,"median":-8.285117,"eighty":-6.004584,"marketCap":993057210},{"date":"2024-12-13","current":-13.920266,"twenty":-10.815972,"median":-8.351032,"eighty":-6.018452,"marketCap":846477455},{"date":"2024-12-20","current":-13.694141,"twenty":-11.182468,"median":-8.50374,"eighty":-6.082845,"marketCap":832727009},{"date":"2024-12-27","current":-14.476534,"twenty":-12.093039,"median":-8.531114,"eighty":-6.098214,"marketCap":880303552},{"date":"2025-01-03","current":-12.794163,"twenty":-13.449021,"median":-8.618187,"eighty":-6.102358,"marketCap":778000234},{"date":"2025-01-10","current":-11.912274,"twenty":-13.190334,"median":-8.707238,"eighty":-6.108649,"marketCap":724373495},{"date":"2025-01-17","current":-10.130408,"twenty":-13.019383,"median":-8.746816,"eighty":-6.115785,"marketCap":616019980},{"date":"2025-01-24","current":-11.197719,"twenty":-12.871045,"median":-8.79431,"eighty":-6.143105,"marketCap":680922085},{"date":"2025-01-31","current":-11.523339,"twenty":-12.794163,"median":-8.877425,"eighty":-6.150011,"marketCap":700722728},{"date":"2025-02-07","current":-12.070562,"twenty":-12.328345,"median":-8.905129,"eighty":-6.232886,"marketCap":733998807},{"date":"2025-02-14","current":-11.432889,"twenty":-12.292165,"median":-8.964497,"eighty":-6.236339,"marketCap":695222549},{"date":"2025-02-21","current":-11.279124,"twenty":-12.151063,"median":-8.998138,"eighty":-6.308164,"marketCap":685872246},{"date":"2025-02-28","current":-9.62841,"twenty":-12.079607,"median":-9.059485,"eighty":-6.342695,"marketCap":585493990},{"date":"2025-03-07","current":-10.297741,"twenty":-11.943932,"median":-9.320702,"eighty":-6.355126,"marketCap":626195310},{"date":"2025-03-14","current":-11.193196,"twenty":-11.879712,"median":-9.419648,"eighty":-6.365485,"marketCap":680647077},{"date":"2025-03-21","current":-14.554795,"twenty":-11.943932,"median":-9.482973,"eighty":-6.379634,"marketCap":724377586},{"date":"2025-03-28","current":-14.68208,"twenty":-12.421509,"median":-9.574004,"eighty":-6.398202,"marketCap":730712447},{"date":"2025-04-04","current":-12.728528,"twenty":-13.089934,"median":-9.668992,"eighty":-6.415901,"marketCap":633486102},{"date":"2025-04-11","current":-10.2603,"twenty":-12.90813,"median":-9.741473,"eighty":-6.42488,"marketCap":510644883},{"date":"2025-04-17","current":-12.761733,"twenty":-12.945214,"median":-9.779811,"eighty":-6.430405,"marketCap":635138674},{"date":"2025-04-25","current":-15.833323,"twenty":-13.271407,"median":-9.84549,"eighty":-6.435239,"marketCap":788008663},{"date":"2025-05-02","current":-15.982746,"twenty":-13.932929,"median":-9.940463,"eighty":-6.440764,"marketCap":795445305},{"date":"2025-05-09","current":-15.25222,"twenty":-14.136351,"median":-10.102399,"eighty":-6.452984,"marketCap":728141003},{"date":"2025-05-16","current":-16.118891,"twenty":-14.245886,"median":-10.138549,"eighty":-6.460191,"marketCap":769515850},{"date":"2025-05-23","current":-16.637714,"twenty":-14.356129,"median":-10.19625,"eighty":-6.460792,"marketCap":794284465},{"date":"2025-05-30","current":-17.410053,"twenty":-14.523491,"median":-10.236057,"eighty":-6.585104,"marketCap":831155927},{"date":"2025-06-06","current":-17.864023,"twenty":-14.65894,"median":-10.342966,"eighty":-6.96771,"marketCap":852828466},{"date":"2025-06-13","current":-17.439532,"twenty":-14.747436,"median":-10.384797,"eighty":-7.264924,"marketCap":832563235}],"updateTime":1750024497691}}}